getITD for FLT3-ITD-based MRD monitoring in AML-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

getITD for FLT3-ITD-based MRD monitoring in AML

Published:2019-05-14 Issue:10 Volume:33 Page:2535-2539
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Blätte Tamara J.,Schmalbrock Laura K.,Skambraks Sabrina,Lux Susanne,Cocciardi Sibylle,Dolnik Anna,Döhner Hartmut,Döhner Konstanze,Bullinger Lars

Funder

Deutsche Forschungsgemeinschaft

Deutsche Krebshilfe

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-019-0483-z.pdf

Reference15 articles.

1. Schuurhuis GJ, Heuser M, Freeman S, Béné M, Buccisano F, Jacqueline Cloos, et al. Minimal/measurable residual disease in AML: consensus document from ELN MRD Working Party. Blood. 2018;131:1275–91.

2. Krauter J, Görlich K, Ottmann O, Lübbert M, Döhner H, Heit W, et al. Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias. J Clin Oncol. 2003;21:4413–22.

3. Krönke J, Schlenk RF, Jensen K, Tschürtz F, Corbacioglu A, Gaidzik VI, et al. Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German–Austrian acute myeloid leukemia study group. J Clin Oncol. 2011;29:2709–16.

4. Döhner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373:1136–52.

5. Ossenkoppele G, Schuurhuis GJ. MRD in AML: does it already guide therapy decision-making? ASH Educ Program Book. 2016;1:356–65.

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clonal Dynamics and Relapse Risk Revealed by High-Sensitivity FLT3-Internal Tandem Duplication Detection in Acute Myeloid Leukemia;Modern Pathology;2024-09

2. Advances in the pathogenesis of FLT3-mutated acute myeloid leukemia and targeted treatments;Current Opinion in Oncology;2024-08-27

3. Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC);Journal of Clinical Oncology;2024-06-20

4. FLT3-TKD Measurable Residual Disease Detection Using Droplet Digital PCR and Clinical Applications in Acute Myeloid Leukemia;International Journal of Molecular Sciences;2024-05-26

5. Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3;Journal of Clinical Oncology;2024-05-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3